EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study

Maha Fathy Elmasry, Yasmine Ahmed Obaid, Solwan Ibrahim El-Samanoudy, Zeinab Ahmed Nour, Sally Sameh Doss

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03115-9 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Maha Fathy Elmasry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Mycosis Fungoides, Interleukins, Skin Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycosis fungoides (MF) is the most common primary cutaneous T-cell lymphoma (CTCL) with its etiology not yet fully understood. Interleukin (IL)-35 is an inhibitory cytokine that belongs to the IL-12 family. Elevated IL-35 in the plasma and the tumor microenvironment increases tumorigenesis and indicates poor prognosis in different types of malignancies. The objective of this study is to estimate the expression levels of IL-35 in tissue and serum of MF patients versus healthy controls. This case-control study included 35 patients with patch, plaque, and tumor MF as well as 30 healthy controls. Patients were fully assessed, and serum samples and lesional skin biopsies were taken prior to starting treatment. The IL-35 levels were measured in both serum and tissue biopsies by ELISA technique. Both tissue and serum IL-35 levels were significantly higher in MF patients than in controls ( P < 0.001) and tissue IL-35 was significantly higher than serum IL-35 in MF patients ( P < 0.001). Tissue IL-35 was significantly higher in female patients and patients with recurrent MF compared to male patients and those without recurrent disease ( P < 0.001). Since both tissue and serum IL-35 levels are increased in MF, IL-35 is suggested to have a possible role in MF pathogenesis. IL-35 can be a useful diagnostic marker for MF. Tissue IL-35 can also be an indicator of disease recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycosis FungoidesInterleukinsSkin NeoplasmsHumansFemaleMaleCase-Control StudiesMiddle AgedAdultSkinAgedBiopsyBiomarkers, Tumor

Stichwörter der Autor:innen

Cutaneous T- cell lymphoma (CTCL)Interleukin (IL-35)LymphocytesMycosis fungoidesPathogenesis

Substanzen

Interleukinsinterleukin-35, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. sally.doss@kasralainy.edu.eg.

Förderung

  • Cairo University

Zitieren

APA

Elmasry, M. F., Obaid, Y. A., El-Samanoudy, S. I., Nour, Z. A., & Doss, S. S. (2024). Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03115-9

Vancouver

Elmasry MF, Obaid YA, El-Samanoudy SI, Nour ZA, Doss SS. Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03115-9

BibTeX
@article{Elmasry2024,
  author = {Elmasry, Maha Fathy and Obaid, Yasmine Ahmed and El-Samanoudy, Solwan Ibrahim and Nour, Zeinab Ahmed and Doss, Sally Sameh},
  title = {Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03115-9}
}
Kostenlos starten →